Class action by businesses in the complementary medicines industry

We successfully defended a class action against five individual officers of the Therapeutic Goods Administration (TGA) worth in excess of $150 million. The class action was brought by 169 businesses in the complementary medicines industry who alleged substantial losses following the suspension by the TGA of the manufacturing licence of Pan Pharmaceuticals and subsequent recall of products. The litigation raised issues concerning the conduct of representative proceedings and involved a complex factual matrix which necessitated a labour intensive forensic factual investigation and assessment. A court-ordered mediation extending over four days resulted in a settlement of the action. The settlement was approved by the Federal Court of Australia. There was no finding nor concession of any wrongdoing by our clients. The compensation paid to the represented class of applicants was provided by the Commonwealth of Australia, which was the first respondent in the proceedings.


Related Articles

Uniting Church in Australia Property Trust (NSW) v Miller; Miller v Lithgow City Council [2015] NSWCA 320

Legal Directions

As a postscript to our Legal Directions article dated 27 October 2015 – which dealt with the NSW Court of Appeal…

Continue reading

Real estate agent was ‘mere conduit’ of vendor in passing on information to prospective purchaser

Legal Directions

Background facts Mrs Hyder, the plaintiff, was the buyer of residential property in Ginahgulla Road in the Sydney suburb of Bellevue…

Continue reading

CAUTION REGARDING EXPERT OPINIONS ON VISUAL PERCEPTION

Legal Directions

Hawkesbury Sports Council v Martin [2019] NSWCA 76 Background The respondent, Ms Apaula Martin, sought damages in negligence against Hawkesbury City…

Continue reading